Hubei Guangji Pharmaceutical Co (SZSE:000952) Other Income (Expense) : ¥-58.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co Other Income (Expense)?

Hubei Guangji Pharmaceutical Co's other income expense for the Hubei Guangji Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ¥0.3 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-58.1 Mil.

Hubei Guangji Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co Other Income (Expense) Chart

Hubei Guangji Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

11.95

22.14

-6.51

-21.60

-60.22

Hubei Guangji Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															-1.78	-9.99	-6.73	-41.73	0.32

Hubei Guangji Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-58.1 Mil.

Hubei Guangji Pharmaceutical Co (SZSE:000952) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Hubei Guangji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030

Website

http://www.guangjipharm.com

Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.

Executives

Zou Guang Ming	Independent director
Guo Shao Zhi	Executives
Zhang Bin	Director
Guo Wen Chao	Supervisors
Sun Zhen Hua	Director
Liao Qing Jiang	Director
Wang Xin	Directors, executives
Hu Feng Lei	Supervisors
Ruan Zhong Yi	Executives
Zhang Ping	Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines